Page 2 - ப்ராடக்ட் சேவை நுகர்பொருட்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ராடக்ட் சேவை நுகர்பொருட்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ராடக்ட் சேவை நுகர்பொருட்கள் Today - Breaking & Trending Today

Synthetic Biology Market worth $30.7 billion by 2026 - Exclusive Report by MarketsandMarkets™


The Factors such as a wide range of applications of synthetic biology, the rising R&D funding and growing initiatives in synthetic biology, declining cost of DNA sequencing and synthesizing, and increasing investments in the market are propelling the growth of this market. However, biosafety, biosecurity, and ethical concerns related to synthetic biology would hamper the growth of this market.
The oligonucleotides and synthetic DNA segment accounted for the largest share of the tool segment in the synthetic biology market in 2020.
On the basis of tool, the market is broadly segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. In 2020, oligonucleotides & synthetic DNA accounted for the largest share of the market for tools. These segments large share can be attributed to factors such as rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range ....

United States , Asia Pacific , Aashish Mehra , Agilent Technologies Inc , Product Service Consumables , Technology Gene Synthesis , Biotechnology Market Research Reports Consulting , Research Insight , Thermo Fisher Scientific Inc , Precigen Inc , Biology Market , Synthetic Cells , Gene Synthesis , Genome Engineering , Tissue Regeneration , Consumer Care , Sample Pages , Thermo Fisher Scientific , Agilent Technologies , Ginkgo Bioworks , Twist Bioscience , Synthetic Genomics , Creative Enzymes , Eurofins Scientific , Adjacent Markets , Biotechnology Market Research Reports ,

Biologics Safety Testing Market worth $6.2 billion by 2026 - Exclusive Report by MarketsandMarkets


Biologics Safety Testing Market worth $6.2 billion by 2026 - Exclusive Report by MarketsandMarkets
Biologics Safety Testing Market
by Product & Service (Consumables, Instrument, Services), Application (Vaccine, Monoclonal Antibodies, Blood products, Cell & Gene Therapy Products), Test Type (Endotoxin, Myoplasm, Sterility Test) - Global Forecast to 2026 , published by MarketsandMarkets, the global market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period.
Browse in-depth TOC on Biologics Safety Testing Market
142 - Tables
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144
The growth of the global biologics safety market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments. ....

United States , Kostenloser Wertpapierhandel , Asia Pacific , Aashish Mehra , Charles River Laboratories Inc , Product Service Consumables , Product Service Assays , Biotechnology Market Research Reports Consulting , Thermo Fisher Scientific Inc , Research Insight , Safety Testing Market , Monoclonal Antibodies , Gene Therapy Products , Test Type , Sterility Test , Safety Testing , Biologics Safety Testing , Sample Pages , Charles River Laboratories , Thermo Fisher Scientific , Wuxi Apptec , Eurofins Scientific , Adjacent Markets , Biotechnology Market Research Reports , Related Reports , Testing Market ,

The Worldwide Immuno-Oncology Assays Industry is Projected to Reach $7.9 Billion by 2026 at a CAGR of 12.5% from 2021


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global immuno-oncology assays market is projected to reach USD 7.9 billion by 2026 from USD 4.4 billion in 2021, at a CAGR of 12.5% during the forecast period.
Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. On the other hand, the requirement of high capital investments and low cost-benefit ratio and the unfavorable regulatory and reimbursement scenario are the major factors hampering the growth of this market.
The consumables segment accounted for the highest growth rate in the immuno-oncology assays market, by product & service, during the forecast period ....

United States , Merck Millipore , Asia Pacific , Technologietransfer Gmb , Laura Wood , Software Services , Nanostring Technologies Inc , Dynamic Companies , Meso Scale Diagnostics , Guardant Health Inc , Progressive Companies , Seegene Inc , Htg Molecular Diagnostics Inc , Porter Five Forces Analysis , Roche Ltd , Invivoscribe Inc , Abbott Laboratories Inc , Office Hours Call , Research Methodology , Asuragen Inc , Product Service , Technology Analysis , Thermo Fisher Scientific Inc , Agilent Technologies Inc , Company Evaluation Quadrant , Perkinelmer Inc ,